Emulsions

Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.

Networked: 642 relevant articles (41 outcomes, 70 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Mayer, Konstantin: 13 articles (01/2015 - 09/2003)
2.	Puder, Mark: 11 articles (09/2015 - 03/2008)
3.	Gura, Kathleen M: 10 articles (09/2015 - 03/2008)
4.	Seeger, Werner: 8 articles (01/2015 - 09/2003)
5.	Ott, Juliane: 6 articles (01/2015 - 02/2007)
6.	Bistrian, Bruce R: 5 articles (02/2015 - 01/2006)
7.	Calder, Philip C: 5 articles (01/2015 - 05/2007)
8.	Heyland, Daren K: 5 articles (01/2015 - 10/2013)
9.	Hecker, Matthias: 5 articles (01/2015 - 02/2010)
10.	Hasselmann, Michel: 4 articles (10/2015 - 12/2004)

Related Diseases

1.	Neoplasms (Cancer) 12/01/2012 - "Immunization with the gp100 peptide delivered in the W/O/W multiple emulsions-based vaccine resulted in increased protection against tumor challenge compared to IFA-based vaccine (p < 0.05, n = 8) signifying induction of enhanced anti-tumor immunity. " 01/01/1998 - "Lectin-functionalized multiple emulsions for improved cancer therapy." 12/01/2009 - "In the current study, oil-in-water emulsions with three different mean diameters (30, 60, and 95 nm) were developed as a new multimodality nanoparticle platform for tumor targeting and imaging. " 11/01/2005 - "The objectives of this prospective, randomized study were to evaluate the efficacy and tolerability of the short-term use of medium-chain triglyceride/long-chain triglyceride (MCT/LCT) fat emulsions, and to compare the hematologic and biochemical effects of MCT/LCT fat emulsions with LCT fat emulsions in gastrointestinal (GI) tract cancer patients following surgery. " 01/01/2013 - "Systemic application of PFC emulsions followed by (1)H/(19)F MRI of mock-infected and GLV-1h68-infected tumor-bearing mice revealed a significant accumulation of the (19)F signal in the tumor rim of virus-treated mice. "
2.	Liver Diseases (Liver Disease) 01/01/2013 - "In young children, n-3FA emulsions resulted in improvement in some biochemical outcomes of intestinal failure-associated liver disease but no difference in mortality. " 01/01/2013 - "This study compares SO and FO lipid emulsions in a murine model of hepatic steatosis, one of the first hits in PN-associated liver disease. " 09/01/2015 - "Finally, the role of parenteral fat emulsions in the pathogenesis and management of PN-associated liver disease in PN-dependent pediatric patients is reviewed. " 01/01/2015 - "Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions." 01/01/2014 - "Commercial ω-6 fatty acid-soybean based-lipid emulsions in PN may mediate long term PN associate liver disease (PNALD) whereas ω-3-fish oil parenteral emulsions have shown to reverse PNALD in children. "
3.	Infection 01/01/2013 - "In a previous study, we showed the effectiveness of (19)F MRI using perfluorocarbon (PFC) emulsions for detecting the site of Staphylococcus aureus infection. " 03/01/2009 - "This study suggests that polyacrylate nanoparticle-containing emulsions may afford promising opportunities for treating both skin and systemic infections." 06/22/2011 - "It was hypothesized that to avoid the injury exerted by gastric fluid, HP has to be sheltered in chyme emulsions immediately on infection. " 05/01/2009 - "Replacement of administration sets used to administer blood, blood products, or lipid emulsions for the prevention of central line-associated bloodstream infection." 06/01/2005 - "These findings show that cationic emulsions can mediate gene transfection into airway epithelium, making it a good choice for transferring therapeutic genes and for genetic vaccination against an pathogenic infection via an airway route."
4.	Eye Diseases (Eye Disease) 05/01/2000 - "Cyclosporin A ophthalmic emulsions, 0.05%, 0.1%, 0.2%, and 0.4%, were safe and well tolerated, significantly improved the ocular signs and symptoms of moderate-to-severe dry eye disease, and decreased the effect of the disease on vision-related functioning. " 01/01/2012 - "Moreover, clinical trials demonstrated the efficacy and safety of cationic emulsions loaded with cyclosporine A in patients with dry eye disease. " 07/01/2009 - "To obtain stable positively charged Azithromycin (AZI) emulsions with a mean droplet size of 120 nm for the treatment of eye diseases. " 10/01/2002 - "Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease." 04/01/2000 - "To compare the efficacy and safety of cyclosporin A ([CsA] 0.05% and 0.1% ophthalmic emulsions) to vehicle in patients with moderate to severe dry eye disease. "
5.	Body Weight (Weight, Body) 07/01/1994 - "Previous studies showed that a new generation of perfluorocarbon (PFC) emulsions increased tissue PO2 in the cat retina to a degree that could not be explained by the small increase in arterial O2 content seen after the infusion of low doses of 1 g PFC/kg body weight. " 01/01/2010 - "Tri[1-14C]oleoylglycerol (14C-OOO) was added to the emulsions administered in Experiment 3. No observable differences were detected in food intake or body weight gain between the BOO and SO groups in Experiment 1. Plasma and liver TAG concentrations and visceral fat weights were significantly lower in the BOO group than in the SO group. " 01/01/2004 - "Lipid emulsions were infused at a rate of 0.125 g fat/kg body weight/h over 6 h. " 01/01/1994 - "Adult Wistar rats were injected intravenously with FDC emulsions stabilized with different emulsifiers at a dose of 11.5 g FDC per kg body weight. " 12/01/1991 - "The fat emulsions were infused continuously at a rate of 0.17 g triglyceride kg-1 body weight (BW)h-1 for 6 h in random order at 7-day intervals. "

Related Drugs and Biologics

1.	Oxygen
2.	Triglycerides (Triacylglycerol)
3.	Soybean Oil
4.	Ethiodized Oil (Ethiodol)
5.	Cyclosporine (Ciclosporin)
6.	Lipids
7.	Omega-3 Fatty Acids (Omega 3 Fatty Acids)
8.	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
9.	Iodized Oil
10.	Niacinamide (Nicotinamide)

Related Therapies and Procedures

1.	Parenteral Nutrition
2.	Injections
3.	Resuscitation
4.	Total Parenteral Nutrition
5.	Radiotherapy